Cannabidiol Oil

Cannabidiol Oil and pregnancy

Caution Advised

• Absorbed into the body
• Fetal development

Cannabidiol (CBD) oil is a hemp-derived ingredient used in cosmetics for its anti-inflammatory and soothing properties. While topical absorption is lower than oral consumption, CBD is lipophilic (fat-soluble) and can penetrate the skin to some degree. The primary concern during pregnancy is the lack of safety data for topical CBD use in pregnant women. According to the FDA, pregnant women should avoid CBD products due to potential fetal developmental risks. Animal studies suggest that high doses of cannabinoids may affect fetal brain development, though these studies involved oral administration rather than topical use. The American College of Obstetricians and Gynecologists (ACOG) advises pregnant women to avoid all cannabis products, including CBD, as a precautionary measure due to insufficient human safety data. While topical CBD in cosmetics has lower systemic absorption than oral products, many obstetricians recommend postponing use until after pregnancy due to the unknowns. The product quality and purity of cosmetic CBD also varies significantly, which adds uncertainty. Women who prioritize caution during pregnancy may wish to avoid CBD-containing products and opt for well-studied anti-inflammatory alternatives.

Cannabidiol Oil and breastfeeding

Caution Advised

• Passes into breast milk
• Infant exposure

CBD oil is a fat-soluble compound that, when absorbed through the skin, could theoretically enter the bloodstream and transfer into breast milk. While topical application results in much lower systemic levels than oral consumption, the lipophilic nature of CBD means it has some potential for accumulation in fatty tissues. The FDA and AAP (American Academy of Pediatrics) recommend that breastfeeding mothers avoid CBD products due to limited safety data. While no specific studies have examined topical CBD use during lactation, research on oral CBD shows it can be detected in breast milk. The concern is potential infant exposure to cannabinoids during a critical period of brain development, even though amounts from topical cosmetic use would be minimal. Most pediatricians and dermatologists advise postponing CBD cosmetics until after weaning as a precautionary measure. The lack of regulation in the CBD cosmetics industry also means product purity cannot be guaranteed, raising additional concerns about contaminants. Breastfeeding mothers seeking anti-inflammatory skincare can choose from many well-studied alternatives.

Cannabidiol Oil and postpartum

Safe to Use

For women who are not breastfeeding, CBD oil in cosmetics poses minimal concerns. The anti-inflammatory properties may help with postpartum skin issues such as sensitivity, redness, or irritation that can occur due to hormonal changes. Without the concern of infant exposure through breast milk, topical CBD can be used safely by postpartum women. However, product quality remains an issue across the CBD cosmetics industry, so choosing reputable brands with third-party testing is advisable. The ingredient may provide soothing benefits for skin recovering from pregnancy-related changes.

Cannabidiol Oil and trying to conceive

Safe to Use

For women trying to conceive, the concerns about topical CBD are primarily precautionary. While there is no evidence that cosmetic CBD use affects fertility, the general medical advice is to minimize exposure to cannabinoids when planning pregnancy due to limited safety data. Topical CBD absorption is minimal compared to oral use, and there is no documented impact on ovulation or conception. However, some women prefer to discontinue CBD products a few months before trying to conceive to eliminate any theoretical risk. This is a personal decision based on individual risk tolerance and medical advice from healthcare providers.

Cannabidiol Oil and PCOS

Safe to Use

CBD oil shows promise for PCOS-related skin concerns due to its anti-inflammatory properties. Emerging research suggests that CBD may help regulate sebum production by interacting with sebaceous gland cells, which could benefit women with PCOS who often experience excess oil and acne. CBD does not appear to directly affect androgen or insulin pathways that are dysregulated in PCOS. Instead, it works through anti-inflammatory mechanisms that may reduce skin inflammation associated with acne. Some preliminary studies suggest CBD has antibacterial properties against acne-causing bacteria. Dermatologists note that while CBD shows theoretical benefits for acne-prone skin, clinical evidence specific to PCOS is limited. Women with PCOS can safely incorporate CBD cosmetics into their routine, though other anti-acne ingredients have more robust research supporting their efficacy. CBD may be most useful as a supplementary ingredient for soothing inflamed skin.

Cannabidiol Oil and general use

Safe to Use

For the general population, topical CBD oil is considered relatively safe with a low risk profile. CBD is non-psychoactive (unlike THC) and has demonstrated anti-inflammatory, antioxidant, and skin-soothing properties in research studies. Many people find it helpful for sensitive or irritated skin conditions. The primary concerns with CBD cosmetics relate to product quality and regulation rather than the ingredient itself. The lack of FDA oversight means products may contain inconsistent CBD concentrations, contaminants, or even unlisted ingredients. Dermatologists recommend choosing CBD products from reputable manufacturers that provide third-party lab testing results. Topical CBD has a good safety profile for most users, with minimal side effects beyond occasional mild irritation. It does not cause the psychoactive effects associated with THC. Research into CBD's dermatological benefits is ongoing, with promising early results for inflammatory skin conditions, though more clinical studies are needed.

Everything else flagged for the same profiles

• Flagged in pregnancy
• Flagged in breastfeeding

Related ingredients

Ingredients suggested in place of Cannabidiol Oil, each one with its own page here.

• Niacinamide
• Colloidal Oatmeal
• Allantoin
• Azelaic Acid

Ingredients that raise the same concerns.

• Cocamide MEAFetal development, Infant exposure, Passes into breast milk
• Benzophenone-4Fetal development, Infant exposure, Passes into breast milk
• Benzophenone-3Fetal development, Infant exposure, Passes into breast milk
• ButylparabenFetal development, Infant exposure, Passes into breast milk
• CamphorFetal development, Infant exposure, Passes into breast milk
• Symphytum Officinale Leaf ExtractFetal development, Infant exposure, Passes into breast milk

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on 15 September 2026.